$CXM

Scott Jacob sold $145K of CXM

Scott Jacob (GENERAL COUNSEL AND CORP. SEC.) sold 26,094 shares of Sprinklr, Inc. (CXM) at $5.55 ($0.14M total) on 2026-09-16.

Original reporting
SEC EDGAR · Scott Jacob
Published Sep 17, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CXM
Neutral
medium confidence
Mentioned
$CXM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CXMNeutralLow
01

Why it matters

The transaction represents a routine disposition by a senior officer, unlikely to move the stock significantly.

02

Market read

Minor relevance; typical insider sale with modest dollar amount.

03

What to watch

Potential upcoming legal matters or compensation restructuring not disclosed.

Relevance 4/10Novelty 4/10Timing: post-market 2026-09-16

Background

Form 4 filings disclose insider trades; investors monitor for material signals.

Company-level read

Ticker impact

$CXMNeutralMedium confidence
Context

General Counsel Scott Jacob sold 26,094 shares of Sprinklr for $144.8K on 2026-09-16.

Expected impact

Minor downward pressure, likely within normal volatility range.

Evidence & confidence

Sale amount is small relative to total holdings; no immediate catalyst beyond routine disposition.

Market effects

Limited impact on the SaaS sector; typical insider transaction.

No regional effect; company is US‑listed.

Negligible global relevance.

Counterpoint

Sale could be unrelated personal liquidity need; not a bearish signal.

Key entities

  • Sprinklr, Inc.

    Customer experience management platform listed on NASDAQ (CXM).

  • Scott Jacob

    General Counsel and Corporate Secretary of Sprinklr.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CXMMed

Sprinklr Earnings Call: AI Momentum Amid Services Drag

Sprinklr (CXM) reported Q2 revenue of $213.7M, up 1% YoY, with subscription revenue growing 3%. Non-GAAP net income was $0.11 per share. Management highlighted strong enterprise deal flow, AI growth, and a record $1.03B in contracted revenue. However, professional services underperformed, with negative gross margins. The company completed a $125M share repurchase program and has $75M remaining under its authorization.

$CXMMedAI 8/10

Sprinklr (CXM) Q2 2027 Earnings Call Transcript

Sprinklr (CXM) reported Q2 2027 revenue of $213.7M, up 1% YoY, with subscription revenue growing 3% YoY. Professional services revenue declined 20% YoY. Non-GAAP operating income was $31.3M, with a 15% margin. Total RPO grew 11% YoY to $1.03B. Q3 revenue guidance is $215M-$216M, with subscription revenue projected at $196M-$197M. CEO Rory Read will lead services organization interim to improve performance. The company added Tom Addis as CRO and Jordi Ribas to its board.

Med

Sprinklr, Inc. Q2 2027 Earnings Call Summary

Sprinklr reported Q2 2027 earnings, highlighting a 30% year-over-year increase in sales transactions and improved renewal rates. The company is transitioning to a unified AI-native platform strategy, with AI investments and weekly innovation cycles. Professional services underperformed due to execution challenges, but management expects margin neutrality soon. Subscription revenue growth is projected to resume in Q3, with a conservative outlook for services. The company completed a $125 million

$CXMMed

Sprinklr’s (NYSE:CXM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Sprinklr (NYSE: CXM) reported Q2 CY2026 revenue of $213.7M, flat year-over-year and in line with estimates. The company expects Q3 revenue of $215.5M, slightly above analyst forecasts. Non-GAAP EPS of $0.11 met expectations. Management guided for a 1.6% YoY decline in Q3 sales. Analysts project flat revenue growth over the next 12 months. The stock fell 2.2% post-earnings to $7.43.